Thomas J. Galloway, MD, Chief of the Division of Head and Neck Radiation Oncology at Fox Chase Cancer Center, was today named a Fellow of the American Society for Radiation Oncology (ASTRO) at its 66th Annual Meeting in Washington, D.C.

“It is an incredible honor to receive this recognition from my professional peers and be welcomed as a fellow of ASTRO,” said Galloway, who is also a Professor in the Department of Radiation Oncology at Fox Chase.

Fellowship in ASTRO recognizes the recipient’s service to the organization and their outstanding contributions to the field of radiation oncology. Galloway will be joining fewer than 500 Fellows within the specialty worldwide, making him one of five at Fox Chase.

Galloway is certified by the American Board of Radiology and specializes in using multidisciplinary approaches to treat cancers of the head and neck, thyroid cancer, skin cancer, and melanoma. He is also chair of the board’s head and neck oral certifying examination committee.

ASTRO’s mission is to advance the specialty of radiation oncology by fostering research and innovation and leading policy developments. The organization helps provide medical education and resources, advocates for patients, and advances science and research vital for radiation oncology. Founded in 1958, ASTRO is committed to improving the lives of people with cancer through radiation therapy.

After earning his medical degree at the University of Florida College of Medicine, Galloway completed an internship in internal medicine at Georgetown University School of Medicine in Washington, D.C. He is a member of the Radiological Society of North America and the American Society of Clinical Oncology.

Throughout his career, Galloway has earned multiple awards and recognitions, including being named to Philadelphia magazine’s Top Doctors list and ARRO Educator of the Year at Fox Chase.

***

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427.